Comparison of Pharmacokinetics and Safety of Two Formulations of Letrozole (2.5 mg) in Healthy Male Volunteers
![]() ![]() |
Noh, Yook-Hwan
(Department of Clinical Pharmacology and Therapeutics, Asan Medical Center)
Bae, Kyun-Seop (Department of Clinical Pharmacology and Therapeutics, Asan Medical Center) Cho, Sang-Heon (Department of Pharmacology and Clinical Pharmacology & Therapeutics, Seoul National University College of Medicine and Hospital) Choe, Sangmin (Clinical Trials Center, Pusan National University Hospital) Ghim, Jong-Lyul (Department of Clinical Pharmacology, Busan Paik Hospital) Jung, Jin Ah (Department of Clinical Pharmacology and Therapeutics, Samsung Medical Center) Kim, Un-Jib (Department of Clinical Pharmacology and Therapeutics, Asan Medical Center) Jin, Seok-Joon (Department of Clinical Pharmacology and Therapeutics, Asan Medical Center) Park, Hyun-Jung (Pharmacokinetic and Pharmacogenetic Laboratory, Clinical Trial Center, Asan Medical Center) Kim, Jung-Chul (Pharmacokinetic and Pharmacogenetic Laboratory, Clinical Trial Center, Asan Medical Center) Lim, Hyeong-Seok (Department of Clinical Pharmacology and Therapeutics, Asan Medical Center) |
1 | Campos SM. Aromatase inhibitors for breast cancer in postmenopausal women. Oncologist, 2004;9(2):126-136. DOI ScienceOn |
2 | Dellapasqua S, Colleoni M. Letrozole. Expert Opin Drug Metab Toxicol, 2010;6(2):251-259. DOI ScienceOn |
3 | KFDA. Korea good clinical practice (KGCP) guidelines. http://clinicaltrials.kfda.go.kr/guide/ laws/board_list.jsp?category_seq=12 [Online] (last visited on 07 July 2012). |
4 | Declaration of Helsinki, Ethical Principles for Medical Research Involving Human Subjects. http://www.wma.net/en/30publications/10policie s/b3/ [Online] (last visited on 07 July 2012). |
5 | Marfil F, Pineau V, Sioufi A, Godbillon SJ. High-performance liquid chromatography of the aromatase inhibitor, letrozole, and its metabolite in biological fluids with automated liquid-solid extraction and fluorescence detection. J Chromatogr B Biomed Appl, 1996;683(2):251-258. DOI ScienceOn |
6 | Zarghi A, Foroutan SM, Shafaati A, Khoddam A. Quantification of carvedilol in human plasma by liquid chromatography using fluorescence detection: application in pharmacokinetic studies. J Pharm Biomed Anal, 2007;44(1):250-253. DOI ScienceOn |
7 | Rowland M, Tozer TN. Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications. 4th ed, Wolters, Kluwer/Lippincott, Williams & Wilkins, 2011. |
8 | KFDA. Bioequivalence guideline in Korea. Published by Korea Food and Drug Administration; http://www.kfda.go.kr/index.kfda?mid=226&pag eNo=1&seq=139&cmd=v [Online] (last visited on July 07 2012). |
9 | Lonning P, Pfister C, Martoni A, Zamagni C. Pharmacokinetics of third-generation aromatase inhibitors. Semin Oncol, 2003;30(4 Suppl 14):23-32. DOI |
10 | Noh YH, Ko YJ, Cho SH, Ghim JL, Choe S, Jung JA, Kim UJ, Jin SJ, Park HJ, Song GS, Lim HS. Pharmacokinetic comparison of 2 formulations of anastrozole (1 mg) in healthy Korean male volunteers: a randomized, singledose, 2-period, 2-sequence, crossover study. Clin Ther, 2012;34(2):305-313. DOI ScienceOn |
![]() |